A Hypothesized Role for Dysregulated Bradykinin Signaling in COVID-19 Respiratory Complications

ASIP member Dr. Joseph Roche (Wayne State University) recently published a paper in FASEB J. along with co-author Dr. Renuka Roche (Eastern Michigan University). Their paper hypothesizes a bradykinin [BK] model for COVID-19 complications and they suggest use of the FDA-approved BK blocker icatibant in the treatment of patients with COVID-19 respiratory disease. The abstract [...]